share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Quaggin Susan E

SEC announcement ·  May 7 18:36
Summary by Moomoo AI
On May 3, 2024, Susan E Quaggin, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock at no cost. The transaction, which was completed on the same day, increased Quaggin's direct holdings in the company to a total of 1,322 shares. The shares granted are of $0.01 par value each, and the grant signifies a direct acquisition of equity in the pharmaceutical company.
On May 3, 2024, Susan E Quaggin, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock at no cost. The transaction, which was completed on the same day, increased Quaggin's direct holdings in the company to a total of 1,322 shares. The shares granted are of $0.01 par value each, and the grant signifies a direct acquisition of equity in the pharmaceutical company.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more